Tumor-Infiltrating Lymphocytes in Endometrial Cancer
1 other identifier
observational
52
1 country
1
Brief Summary
Endometrial cancer (EC) is a leading cancer among women globally. The tumor microenvironment in EC is characterized by complex interactions between cancer cells and immune components. Among these proteins, CD133, WNT-1, and mTOR have emerged as key molecular markers with potential prognostic and therapeutic implications in EC. Understanding the association between these molecular alterations and the immune contexture of EC can provide valuable insights into EC biology and lead to the identification of novel therapeutic targets. In this study, the spatial organization of tumor-infiltrating lymphocytes (TILs) in EC and their correlations with tumor grade, stage, and subcellular CD133, WNT-1, and mTOR expression were investigated. Artificial intelligence-assisted image analysis was performed to quantify TIL metrics, including TIL percentage, grey level co-occurrence matrix (GLCM M1 and M2) parameters, and fractal dimension (FD).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 8, 2025
CompletedFirst Submitted
Initial submission to the registry
May 9, 2025
CompletedFirst Posted
Study publicly available on registry
May 16, 2025
CompletedMay 16, 2025
May 1, 2025
5 months
May 9, 2025
May 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
TIL percentage [%]
TIL percentage is the area occupied by lymphocytes divided by the cancer area, expressed as a percentage \[%\]
up to 6 months
GLCM M1 (×10⁶)
GLCM is a second-order statistical method for texture feature extraction. Structured images typically contain numerous pixel pairs with co-occurring low- and high-intensity values. After GLCM calculation, different weights were applied to each matrix element to derive two measures: M1 and M2, representing areas with low and high intensities, respectively. Lower M1 and higher M2 values characterize more structured images with distinct TIL patterns. GLCM M1 values are scaled and expressed in millions (×10⁶), with lower values indicating more structured TIL patterns.
up to 6 months
FD
FD provides a statistical index of pattern complexity in geometric structures. Higher FD values thus indicate more structured and complex TIL distribution patterns
up to 6 months
GLCM M2 (×10³)
GLCM is a second-order statistical method for texture feature extraction. Structured images typically contain numerous pixel pairs with co-occurring low- and high-intensity values. After GLCM calculation, different weights were applied to each matrix element to derive two measures: M1 and M2, representing areas with low and high intensities, respectively. Lower M1 and higher M2 values characterize more structured images with distinct TIL patterns. GLCM M2 values are scaled and expressed in thousands (×10³), with higher values indicating increased TIL clustering.
up to 6 months
Study Arms (2)
Low-grade Endometrial Cancer
Histological grade G1 and G2
High-grade Endometrial Cancer
Histological grade G3
Interventions
TIL percentage was calculated as the area occupied by lymphocytes divided by the cancer area, expressed as a percentage \[%\]
The GLCM is a second-order statistical method for texture feature extraction. Structured images typically contain numerous pixel pairs with co-occurring low- and high-intensity values. After GLCM calculation, different weights were applied to each matrix element to derive two measures: M1 and M2, representing areas with low and high intensities, respectively. Lower M1 and higher M2 values characterized more structured images with distinct TIL patterns.
Quantification of the complexity of TIL
Eligibility Criteria
Archival properly stored formalin-fixed paraffin-embedded tissue blocks from endometrial cancer tissue of women age at leat 18.
You may qualify if:
- confirmed diagnosis of EC
- adequate quality of archival material
- absence of prior neoadjuvant treatment
- complete medical documentation
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jagiellonian University
Krakow, Poland
Biospecimen
archival formalin-fixed paraffin-embedded tissue blocks
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Milosz Pietrus, PhD
Jagiellonian University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 9, 2025
First Posted
May 16, 2025
Study Start
December 1, 2024
Primary Completion
April 30, 2025
Study Completion
May 8, 2025
Last Updated
May 16, 2025
Record last verified: 2025-05